Welcome to the Journal of Renal and Hepatic Disorders

Main Article Content

Jeffrey Halldorson


Editorial, Renal, Hepatic Disorders


Welcome to the inaugural issue of the Journal of Renal and Hepatic Disorders. The aim of the journal is to promote the study and dissemination of research involving both renal and hepatic organ systems and their impact on the whole organism in both healthy and diseased states. In addition, the focus of the journal will provide a unique forum in which the interdependence and interactions between the liver and kidney will be of particular interest.


Download data is not yet available.
Abstract 761 | PDF Downloads 242 HTML Downloads 346 XML Downloads 76


1. Kanubhai Sutariya V, Tank A, Ramanlal Modi P. Combinedliver-kidney transplantation for hepatorenal syndrome. Int JOrgan Transplant Med. 2015;6(3):131–3.
2. Rognant N. Acute kidney injury in patients with chronic liver disease. World J Hepatol. 2015;7(7):993–1000. http://dx.doi.org/10.4254/wjh.v7.i7.993
3. Jindal A, Bhadoria AS, Maiwall R, Sarin SK. Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure. Liver Int. 2016;36(1):59–67. http://dx.doi.org/10.1111/liv.12895
4. Sung RS, Wiseman AC. Simultaneous liver-kidney transplant: Too many or just enough? Adv Chronic Kidney Dis. 2015;22(5):399–403. http://dx.doi.org/10.1053/j.ackd.2015.06.005
5. Brennan TV, Lunsford KE, Vagefi PA, Bostrom A, Ma M, Feng S. Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction. Clin Transplant. 2015;29(1):34–43. http://dx.doi.org/10.1111/ctr.12479
6. Mosconi G, Roi GS, Totti V, Zancanaro M, Tacconi A, Todeschini P, et al. Renal function in kidney and liver transplant recipients after a 130-km road cycling race. Transplant Direct. 2015;1(9):e36. http://dx.doi.org/10.1097/TXD.0000000000000546
7. Pipili C, Cholongitas E. Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipients. World J Gastrointest Pharmacol Ther. 2015;6(4):105–10. http://dx.doi.org/10.4292/wjgpt.v6.i4.105
8. Vliegenthart AD, Shaffer JM, Clarke JI, Peeters LE, Caporali A, Bateman DN, et al. Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury. Sci Rep. 2015;5:15501. http://dx.doi.org/10.1038/srep15501
9. Musso G, Cassader M, Cohney S, Pinach S, Saba F, Gambino R. Emerging liver-kidney interactions in nonalcoholic fatty liver disease. Trends Mol Med. 2015;21(10):645–62. http://dx.doi.org/10.1016/j.molmed.2015.08.005
10. Chan K, Busque SM, Sailer M, Stoeger C, Broer S, Daniel H, et al. Loss of function mutation of the Slc38a3 glutamine transporter reveals its critical role for amino acid metabolism in the liver, brain, and kidney. Pflugers Arch. 2016;468(2):213–27. http://dx.doi.org/10.1007/s00424-015-1742-0
11. Hack V, Gross A, Kinscherf R, Bockstette M, Fiers W, Berke G, et al. Abnormal glutathione and sulfate levels after interleukin 6 treatment and in tumor-induced cachexia. FASEB J. 1996;10(10):1219–26.
12. Gevers TJ, Hol JC, Monshouwer R, Dekker HM, Wetzels JF, Drenth JP. Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: An observational trial. Liver Int. 2015;35(5):1607–14. http://dx.doi.org/10.1111/liv.12726